Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161282303> ?p ?o ?g. }
- W2161282303 endingPage "92" @default.
- W2161282303 startingPage "92" @default.
- W2161282303 abstract "To evaluate the efficacy and safety of intravitreal bevacizumab for polypoidal choroidal vasculopathy (PCV).In this retrospective interventional pilot study, 12 eyes of 11 patients with active PCV were treated with intravitreal bevacizumab (1.25 mg) alone or in combination with photodynamic therapy (PDT) depending on the informed patient's choice. Intravitreal bevacizumab was repeated at 6-week intervals until the regression of active lesion was detected on fluorescein angiography (FA) which was done on a regular basis, Indocyanine green angiography (ICGA) and optical coherence tomography (OCT) analyses.Intravitreal bevacizumab was given alone in 8 eyes (Group 1) and in combination with PDT in 4 eyes (Group 2). Mean follow-up duration was 17 weeks in group 1 and 15 weeks in group 2 after bevacizumab treatment. The mean number of bevacizumab injections was 2.2 in group 1 and 2.5 in group 2. Mean BCVA improved from 20/63 to 20/40 in group 1 and 20/63 to 20/32 in group 2. Of all eyes, the BCVA improved by > or = 2 lines in seven (58%) eyes and resolution of fluid and hemorrhages in clinical examination, an absence of leakage on repeat FAs, or resolved pigment epithelial detachment (PED) and/or subretinal fluid (SRF) on OCT exam was confirmed in 10 (83%) eyes. Partial or complete regression of the polypoidal vessels and interconnecting vessels was reported for most cases at the last follow-up. No significant ocular or systemic side effects were observed in both groups.Short-term results indicate that intravitreal bevacizumab (1.25 mg) alone or in combination with PDT is well tolerated and associated with improvement in BCVA and reduced angiographic leakage in most patients. Further evaluation of intravitreal bevacizumab therapy for the treatment of PCV is warranted." @default.
- W2161282303 created "2016-06-24" @default.
- W2161282303 creator A5009494138 @default.
- W2161282303 creator A5026760645 @default.
- W2161282303 creator A5044685974 @default.
- W2161282303 creator A5083290759 @default.
- W2161282303 creator A5090675984 @default.
- W2161282303 date "2008-01-01" @default.
- W2161282303 modified "2023-09-30" @default.
- W2161282303 title "The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy" @default.
- W2161282303 cites W1481983591 @default.
- W2161282303 cites W1513613431 @default.
- W2161282303 cites W1768895213 @default.
- W2161282303 cites W193593035 @default.
- W2161282303 cites W1965290683 @default.
- W2161282303 cites W1968609549 @default.
- W2161282303 cites W1970803198 @default.
- W2161282303 cites W1974272630 @default.
- W2161282303 cites W1987722557 @default.
- W2161282303 cites W2015616513 @default.
- W2161282303 cites W2023874692 @default.
- W2161282303 cites W2024043198 @default.
- W2161282303 cites W2024921134 @default.
- W2161282303 cites W2032358631 @default.
- W2161282303 cites W2033245558 @default.
- W2161282303 cites W2036516882 @default.
- W2161282303 cites W2054180058 @default.
- W2161282303 cites W2054334822 @default.
- W2161282303 cites W2062478098 @default.
- W2161282303 cites W2064729755 @default.
- W2161282303 cites W2080591818 @default.
- W2161282303 cites W2099006228 @default.
- W2161282303 cites W2119253030 @default.
- W2161282303 cites W2139795069 @default.
- W2161282303 cites W2143419021 @default.
- W2161282303 cites W2155683225 @default.
- W2161282303 cites W2233259956 @default.
- W2161282303 cites W2336200237 @default.
- W2161282303 cites W3048476598 @default.
- W2161282303 cites W4249438516 @default.
- W2161282303 doi "https://doi.org/10.3341/kjo.2008.22.2.92" @default.
- W2161282303 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2629943" @default.
- W2161282303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18612226" @default.
- W2161282303 hasPublicationYear "2008" @default.
- W2161282303 type Work @default.
- W2161282303 sameAs 2161282303 @default.
- W2161282303 citedByCount "60" @default.
- W2161282303 countsByYear W21612823032012 @default.
- W2161282303 countsByYear W21612823032013 @default.
- W2161282303 countsByYear W21612823032014 @default.
- W2161282303 countsByYear W21612823032015 @default.
- W2161282303 countsByYear W21612823032016 @default.
- W2161282303 countsByYear W21612823032017 @default.
- W2161282303 countsByYear W21612823032019 @default.
- W2161282303 countsByYear W21612823032021 @default.
- W2161282303 countsByYear W21612823032022 @default.
- W2161282303 crossrefType "journal-article" @default.
- W2161282303 hasAuthorship W2161282303A5009494138 @default.
- W2161282303 hasAuthorship W2161282303A5026760645 @default.
- W2161282303 hasAuthorship W2161282303A5044685974 @default.
- W2161282303 hasAuthorship W2161282303A5083290759 @default.
- W2161282303 hasAuthorship W2161282303A5090675984 @default.
- W2161282303 hasBestOaLocation W21612823031 @default.
- W2161282303 hasConcept C118487528 @default.
- W2161282303 hasConcept C141071460 @default.
- W2161282303 hasConcept C2776694085 @default.
- W2161282303 hasConcept C2777802072 @default.
- W2161282303 hasConcept C2778257484 @default.
- W2161282303 hasConcept C2780248432 @default.
- W2161282303 hasConcept C71924100 @default.
- W2161282303 hasConceptScore W2161282303C118487528 @default.
- W2161282303 hasConceptScore W2161282303C141071460 @default.
- W2161282303 hasConceptScore W2161282303C2776694085 @default.
- W2161282303 hasConceptScore W2161282303C2777802072 @default.
- W2161282303 hasConceptScore W2161282303C2778257484 @default.
- W2161282303 hasConceptScore W2161282303C2780248432 @default.
- W2161282303 hasConceptScore W2161282303C71924100 @default.
- W2161282303 hasIssue "2" @default.
- W2161282303 hasLocation W21612823031 @default.
- W2161282303 hasLocation W21612823032 @default.
- W2161282303 hasLocation W21612823033 @default.
- W2161282303 hasLocation W21612823034 @default.
- W2161282303 hasOpenAccess W2161282303 @default.
- W2161282303 hasPrimaryLocation W21612823031 @default.
- W2161282303 hasRelatedWork W1987013993 @default.
- W2161282303 hasRelatedWork W2019061366 @default.
- W2161282303 hasRelatedWork W2025214768 @default.
- W2161282303 hasRelatedWork W2031205148 @default.
- W2161282303 hasRelatedWork W2053648830 @default.
- W2161282303 hasRelatedWork W2148112122 @default.
- W2161282303 hasRelatedWork W2211181535 @default.
- W2161282303 hasRelatedWork W2577193304 @default.
- W2161282303 hasRelatedWork W3029840409 @default.
- W2161282303 hasRelatedWork W4243304339 @default.
- W2161282303 hasVolume "22" @default.
- W2161282303 isParatext "false" @default.
- W2161282303 isRetracted "false" @default.
- W2161282303 magId "2161282303" @default.